This study has been designed to demonstrate that red blood cell from umbilical cord blood (UCB-RBC) is a safe and available product for extremely preterm infants (EPI) transfusion and that transfusion of UCB-RBC is non-less effective than RBC from adult donor for the treatment of anemia of prematurity in this group of patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of participants with abnormal physical examination after red blood cells from umbilical cord blood (UCB-RBC) transfusion
Timeframe: 24 hours after the procedure
Number of participants with abnormal vital signs after UCB-RBC transfusion
Timeframe: 24 hours after the procedure
Number of participants with altered value of continous monitoring of regional cerebral and somatic oxygen saturation by near-infrared spectroscopy after UCB-RBC transfusion
Timeframe: 24 hours after the procedure
Number of participants with abnormalities in the result of acid-base balance and ionogram after UCB-RBC transfusion
Timeframe: 24 hours after the procedure
Number of participants with morbidities up to 36 weeks of postmenstrual age after UCB-RBC transfusion
Timeframe: 24 hours after the procedure